Navigation Links
Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
Date:10/2/2007

sed on cancer research.

"SDI is focused on the oncology segment of life science research and is committed to creating industry leading solutions for oncology research," Mr. Knight added. "This initial offering is a powerful step in that direction. As we expand this catalog, it will become the premier site for new and important antibody reagents for cancer research."

About Strategic Diagnostics, Inc.

Strategic Diagnostics Inc. develops, manufactures and markets biotechnology-based detection solutions to a diverse customer base, across multiple industrial and human health markets. By applying its core competency of creating custom antibodies to assay development, the Company produces unique, sophisticated diagnostic testing and reagent systems that are responsive to customer diagnostic and information needs. Customers benefit with quantifiable "return on investment" by reducing time, labor, and/or material costs. All this is accomplished while increasing accuracy, reliability and actionability of essential test results. The Company is focused on sustaining this competitive advantage by leveraging its expertise in immunology, proteomics, bio-luminescence and other bio-reactive technologies to continue its successful customer-focused research and development efforts. Recent innovations in high throughput production of antibodies from genetic antigens will complement the Company's established leadership in commercial and custom antibody production for the Research, Human/Animal Diagnostics, and Pharmaceutical industries, and position the Company for broader participation in the pharmacogenomics market.

This news release contains forward-looking statements reflecting SDI's current expectations. When used in this press release, the words "anticipate", "could", "enable", "estimate", "intend", "expect", "believe", "potential", "will", "should", "project" "plan" and similar expressions as they relate to SDI are intended to identify said forward-looking
'/>"/>

SOURCE Strategic Diagnostics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Answerthink and LORENZ Life Sciences Group Announce Strategic Alliance for the SAP Life Science Industry
2. New Advances in Gastric Diagnostics: Smaller is Better
3. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
4. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
7. Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
8. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
9. Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
10. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
11. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  Luminex Corporation (NASDAQ: ... the Morgan Stanley Global Healthcare Conference to be held ... Hotel in New York City . ... a.m. Eastern time on Friday, September 18, 2015.  The ... Luminex Corporation,s website at http://www.luminexcorp.com . Simply log on ...
(Date:9/4/2015)... , September 4, 2015 ... by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by ... and by Product - Global Forecast to 2020", published ... reach USD 2.5 Billion by 2020, growing at a ... to 2020. Browse 139 Tables and ...
(Date:9/4/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Rodman & Renshaw 17 th Annual Global Investment ... New York City .  Dr. Michael Berelowitz ... on September 9, 2015. Presentation Details: ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3
... UPI ), a medical device company ... to treat voiding dysfunctions, today announced that Noridian ... both regional Medicare carriers, now cover percutaneous, posterior ... Neuromodulation System for the treatment of the symptoms ...
... was voted the most powerful person in healthcare by readers ... business news magazine. It,s the second consecutive year Obama topped ... in Healthcare. "The passage of national healthcare reform ... Modern Healthcare Editor David Burda. "The Patient Protection ...
Cached Medicine Technology:Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplasty's Urgent® PC Neuromodulation System 2Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplasty's Urgent® PC Neuromodulation System 3Obama Named the Most Powerful Person in Healthcare for Second Consecutive Year 2
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... and the surrounding communities, is launching a charity effort to provide for the ... referred to as an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction ...
(Date:9/4/2015)... ... 04, 2015 , ... Keeping mold top of mind is important when considering ... Mold can grow anywhere - on carpet, clothing, food, paper, and even in places ... water in the home is key to preventing mold growth, which if exposed to ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a ... announced its only mission and research focus: Water Life Science®. In the current ... water evaporation is becoming dangerously accelerated. As a result of the global fresh ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Lalonde Gordon ran ... and followed up with victory in the men’s 400 meters final, with an impressive ... and Field Championships in San Jose, Costa Rica in August 2015. The 44.64 time ...
(Date:9/4/2015)... ... September 04, 2015 , ... EMED Jamaica Global Ltd. ... it has entered into a multi-year agreement with Health City Cayman Islands. , ... link between American healthcare, Jamaican healthcare and Health City Cayman Islands to deliver ...
Breaking Medicine News(10 mins):Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6
... Control Research Center, the Center for Injury Research ... School of Public Heath, Tongji Medical College at ... Agricultural Injury Research Training Project was created in ... Chinese scholars, expand collaborative research activities between the ...
... Reporter , MONDAY, July 26 (HealthDay News) -- Too ... of prostate-specific antigen (PSA) is normal or below normal, ... Recent evidence has shown that among older men with ... from, but another condition. For these men, watchful waiting ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... harnessed the power of the sniff to help severely disabled ... move around in wheelchairs. The experimental "sniff controller" takes ... are often not damaged and are still able to send ...
... survival is associated with increased risk of long-term abnormalities ... July 26 issue of Archives of Internal Medicine ... background in the article, childhood cancer survival rates have ... 70 to 80 percent currently. The authors also note ...
... About 1 in 10 people have the potential to ... with this devastating illness. The challenge is in knowing why ... years of laboratory study, Mark F. Lenzenweger, a distinguished professor ... thinks that not only does he have the makings of ...
... MONDAY, July 26 (HealthDay News) -- Recent reports questioning the ... may shun the very products that could save their lives, ... allegations -- that many topical sunscreens can cause skin cancer, ... is dubious at best, said Dr. Jeffrey Dover, president of ...
Cached Medicine News:Health News:Trainee publication highlights success of US-China agricultural injury research training project 2Health News:Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study Shows 2Health News:Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study Shows 3Health News:Sniffing Device Allows Disabled to Write, Run Wheelchairs 2Health News:Sniffing Device Allows Disabled to Write, Run Wheelchairs 3Health News:Childhood cancer survivors may have abnormal long-term cardiac function 2Health News:New book offers cutting-edge perspective on causes of schizophrenia; related disorders 2Health News:Sunscreen Concerns Unfounded, Experts Say 2Health News:Sunscreen Concerns Unfounded, Experts Say 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: